| 1 |
28842826 | Environmental Enrichment Reverses Tyrosine Kinase Inhibitor-Mediated Impairment Through BDNF-TrkB Pathway. | 2018 Jan |
2 |
| 2 |
29517106 | Vandetanib has antineoplastic activity in anaplastic thyroid cancer, in vitro and in vivo. | 2018 May |
1 |
| 3 |
29787277 | Targeting of EGFR, VEGFR2, and Akt by Engineered Dual Drug Encapsulated Mesoporous Silica-Gold Nanoclusters Sensitizes Tamoxifen-Resistant Breast Cancer. | 2018 Jul 2 |
1 |
| 4 |
30210625 | NCOA4-RET fusion in colorectal cancer: Therapeutic challenge using patient-derived tumor cell lines. | 2018 |
1 |
| 5 |
26050198 | ZD6474, a new treatment strategy for human osteosarcoma, and its potential synergistic effect with celecoxib. | 2015 Aug 28 |
1 |
| 6 |
24256343 | Changes in signaling pathways induced by vandetanib in a human medullary thyroid carcinoma model, as analyzed by reverse phase protein array. | 2014 Jan |
2 |
| 7 |
24526731 | Inhibition of RET increases the efficacy of antiestrogen and is a novel treatment strategy for luminal breast cancer. | 2014 Apr 15 |
1 |
| 8 |
23578175 | Identification of a lung adenocarcinoma cell line with CCDC6-RET fusion gene and the effect of RET inhibitors in vitro and in vivo. | 2013 Jul |
1 |
| 9 |
23799852 | Autophagy inhibition induces enhanced proapoptotic effects of ZD6474 in glioblastoma. | 2013 Jul 9 |
2 |
| 10 |
23822199 | Changes in signaling pathways induced by vandetanib in a human medullary thyroid carcinoma model, as analyzed by reverse phase protein array. | 2013 Jul 3 |
2 |
| 11 |
21350000 | Vandetanib restores head and neck squamous cell carcinoma cells' sensitivity to cisplatin and radiation in vivo and in vitro. | 2011 Apr 1 |
1 |
| 12 |
21970874 | Preclinical emergence of vandetanib as a potent antitumour agent in mesothelioma: molecular mechanisms underlying its synergistic interaction with pemetrexed and carboplatin. | 2011 Nov 8 |
1 |
| 13 |
20139705 | ZD6474, a dual tyrosine kinase inhibitor of EGFR and VEGFR-2, inhibits MAPK/ERK and AKT/PI3-K and induces apoptosis in breast cancer cells. | 2010 Apr 15 |
2 |
| 14 |
19318229 | Growth inhibition by tyrosine kinase inhibitors in mesothelioma cell lines. | 2009 Jun |
1 |
| 15 |
19622715 | Abrogation of mitogen-activated protein kinase and Akt signaling by vandetanib synergistically potentiates histone deacetylase inhibitor-induced apoptosis in human glioma cells. | 2009 Oct |
2 |
| 16 |
18694994 | Vascular endothelial growth factor receptor-1 contributes to resistance to anti-epidermal growth factor receptor drugs in human cancer cells. | 2008 Aug 15 |
2 |
| 17 |
21479415 | Antitumor activity of ZD6474 in a metastatic orthotopic brain tumor model. | 2008 May-Jun |
1 |
| 18 |
17308046 | Targeted therapy of orthotopic human lung cancer by combined vascular endothelial growth factor and epidermal growth factor receptor signaling blockade. | 2007 Feb |
1 |
| 19 |
16995874 | ZD6474 induces growth arrest and apoptosis of GIST-T1 cells, which is enhanced by concomitant use of sunitinib. | 2006 Dec |
2 |
| 20 |
17145834 | Synergistic antitumor activity of ZD6474, an inhibitor of vascular endothelial growth factor receptor and epidermal growth factor receptor signaling, with gemcitabine and ionizing radiation against pancreatic cancer. | 2006 Dec 1 |
1 |